Radetec Diagnostics is a Melbourne-based biotech company specialised in the development, production, and commercialisation of rapid tests.
Radetec core innovations are:
- “MultiD”, a new way to detect multiple biomarkers on the same strip;
- “EasyConj”, a new type of fluorescent nanoparticle ideal for medical imaging, biomarker screening, and sensing.
Radetec is using these two technologies to develop a self-test for chlamydia and gonorrhoea, the two most prevalent sexually transmitted infections (STIs) worldwide, more sensitive than other rapid tests currently on the market. For more information, visit: https://radetecdiagnostics.com/
Radetec Diagnostics has also developed a complete suite of reagents and equipment for R&D, which is available for purchase at: www.lateralflows.com
Connect Program representatives
John Li, CEO
Dr. Li holds a bachelor's degree in Biomedical Science and a master’s degree in Chemistry, both earned at the University of Melbourne. In 2016, he successfully completed his PhD in Chemistry at the University of Melbourne, where he was jointly supervised by Prof. Paul Mulvaney and Prof. Jonathan White. With over a decade of expertise in quantum dots research and organic chemistry, Dr. Li has demonstrated his prowess in these fields. Additionally, he brings with him a wealth of entrepreneurial experience, having spent 5 successful years in the education industry prior to his current endeavours.
Fabio Lisi CTO
Dr. Lisi holds a bachelor's degree in Industrial Chemistry and a master's degree in Materials Science, both earned at the University of Pisa (Italy). In 2016, he successfully completed his PhD in Chemistry at the University of Melbourne, where he was jointly supervised by Prof. Paul Mulvaney and Prof. Paolo Falcaro (CSIRO).
With over 10 years of research experience in Italy, Australia, and Japan, Dr. Lisi has worked at esteemed institutions, including the University of Melbourne, the University of New South Wales, and the University of Tokyo. Throughout his career, he has been involved in complex and interdisciplinary projects, both in research and in industry, developing key expertise in research and industry, gaining key expertise in nanomaterial synthesis and the development of cutting-edge biosensors.
